The first two cases of candida auris in the Netherlands

Candida auris is a rapidly emerging multidrug-resistant pathogenic yeast. In recent years, an increasing number of C. auris invasive infections and colonized patients have been reported, and C. auris has been associated with hospital outbreaks worldwide, mainly in intensive care units (ICUs). Here, we describe the first two cases of C. auris in The Netherlands. Both cases were treated in a healthcare facility in India prior to admission. The patients were routinely placed in contact precautions in a single room after admission, which is common practice in The Netherlands for patients with hosp... Mehr ...

Verfasser: Vogelzang, Erik H.
Weersink, Annemarie J. L.
Mansfeld, Rosa Van
Chow, Nancy A.
Meis, Jacques F.
Dijk, Karin Van
Dokumenttyp: Artikel
Erscheinungsdatum: 2019
Reihe/Periodikum: Vogelzang , E H , Weersink , A J L , Mansfeld , R V , Chow , N A , Meis , J F & Dijk , K V 2019 , ' The first two cases of candida auris in the Netherlands ' , Journal of Fungi , vol. 5 , no. 4 , 91 . https://doi.org/10.3390/jof5040091
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26845577
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.vumc.nl/en/publications/05b609a3-2588-4843-9ffa-fe8fd6836ba6

Candida auris is a rapidly emerging multidrug-resistant pathogenic yeast. In recent years, an increasing number of C. auris invasive infections and colonized patients have been reported, and C. auris has been associated with hospital outbreaks worldwide, mainly in intensive care units (ICUs). Here, we describe the first two cases of C. auris in The Netherlands. Both cases were treated in a healthcare facility in India prior to admission. The patients were routinely placed in contact precautions in a single room after admission, which is common practice in The Netherlands for patients with hospitalization outside The Netherlands. No transmission of C. auris was noticed in both hospitals. Routine admission screening both for multidrug-resistant (MDR) bacteria and MDR yeasts should be considered for patients admitted from foreign hospitals or countries with reported C. auris transmission.